173 related articles for article (PubMed ID: 27815475)
41. A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases.
Janssen S; Haus R; Schild SE; Rades D
Anticancer Res; 2020 Jan; 40(1):367-371. PubMed ID: 31892588
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
43. Palliative radiotherapy for bone metastases at the end of life in Victoria.
Ong WL; Foroudi F; Milne RL; Millar JL
Med J Aust; 2021 Mar; 214(5):236-237.e1. PubMed ID: 33610136
[No Abstract] [Full Text] [Related]
44. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
[TBL] [Abstract][Full Text] [Related]
45. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
46. Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer.
Haus R; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(2):679-682. PubMed ID: 32111769
[TBL] [Abstract][Full Text] [Related]
47. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer.
Johansen JS; Cintin C; Jørgensen M; Kamby C; Price PA
Eur J Cancer; 1995; 31A(9):1437-42. PubMed ID: 7577068
[TBL] [Abstract][Full Text] [Related]
48. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
[TBL] [Abstract][Full Text] [Related]
49. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
[TBL] [Abstract][Full Text] [Related]
50. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
[TBL] [Abstract][Full Text] [Related]
51. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
52. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
54. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
55. Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014.
Yu JB; Pollack CE; Herrin J; Zhu W; Soulos PR; Xu X; Gross CP
Am J Clin Oncol; 2019 Jun; 42(6):493-499. PubMed ID: 31033511
[TBL] [Abstract][Full Text] [Related]
56. Reirradiation with local-field radiotherapy for painful bone metastases.
Hayashi S; Hoshi H; Iida T
Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102
[TBL] [Abstract][Full Text] [Related]
57. Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P; Migliaccio F; Angelini V; Cante D; Sciacero P; Peruzzo Cornetto A; Casanova Borca V; Zeverino M; Torielli P; Arrichiello C; Girelli G; La Porta MR; Tofani S; Numico G; Ricardi U
Cancer Invest; 2014 Nov; 32(9):458-63. PubMed ID: 25259607
[TBL] [Abstract][Full Text] [Related]
58. Radiation Therapy and Palliative Care Prolongs the Survival of Hepatocellular Carcinoma Patients with Bone Metastases.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Fukushima S; Saito T
Intern Med; 2016; 55(9):1077-83. PubMed ID: 27150858
[TBL] [Abstract][Full Text] [Related]
59. Radiotherapy effects on brain/bone metastatic adenocarcinoma lung cancer and the importance of EGFR mutation test.
Qu BL; Cai BN; Yu W; Liu F; Huang YR; Ju ZJ; Wang XS; Ou GM; Feng LC
Neoplasma; 2016; 63(1):158-62. PubMed ID: 26639246
[TBL] [Abstract][Full Text] [Related]
60. Early palliative radiation therapy in patients with newly diagnosed cancer: Reasons, clinical practice, and survival.
Nieder C; Haukland E; Mannsåker B; Pawinski A; Dalhaug A
Pract Radiat Oncol; 2015; 5(5):e537-e542. PubMed ID: 25823382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
